Related Experiment Video
Updated: May 3, 2026

Measuring Uptake of the Glucose Analog, 6-(N-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)Amino)-6-Deoxyglucose, in Intact Murine Neural Retina
Published on: March 14, 2025
Glucose transporter 9 inhibition as a potential novel approach for lowering uric acid
Katsuya Deai1, Kenji Fukui1, Shiori Naruoka1
1Central Pharmaceutical Research Institute, Japan Tobacco Inc., 1-1, Murasaki-cho, Takatsuki, Osaka, 569-1125, Japan.
Abstract:
Glucose transporter 9 (GLUT9) is a uric acid transporter that plays a key role in maintaining uric acid homeostasis. JTT-763 is a novel GLUT9 inhibitor identified based on its uric acid transport inhibitory activity against human GLUT9 (hGLUT9). Using JTT-763 as a pharmacological tool, we aimed to evaluate the concept of GLUT9 inhibition for urate lowering. In vitro, JTT-763 inhibited uric acid transport by hGLUT9 short form (hGLUT9S) and hGLUT9 long form (hGLUT9L) in a concentration-dependent manner and showed high selectivity for hGLUT9 over other uric acid-related molecules. JTT-763 also inhibited uric acid transport through hGLUT9S/L co-expressing cells, a model that mimics renal uric acid reabsorption in vivo. In mice, JTT-763 increased uric acid excretion in urine but did not significantly affect blood uric acid levels. Therefore, we evaluated JTT-763 in tufted capuchin monkeys, whose uric acid metabolism is relatively similar to humans. JTT-763 showed a significant dose-dependent decrease in blood uric acid levels, and this effect was stronger than that of benzbromarone, an existing uricosuric drug, on a dose basis. Unexpectedly, benzbromarone significantly increased urinary uric acid excretion in monkeys, whereas JTT-763 did not. These results suggest that GLUT9 inhibition increases uric acid excretion not only in the kidney but also from extrarenal tissues and may represent a novel urate-lowering approach for hyperuricemia.
More Related Videos
10:35Extracellular Glucose Depletion as an Indirect Measure of Glucose Uptake in Cells and Tissues Ex Vivo
Published on: April 6, 2022
10:02Quantitative SERS Detection of Uric Acid via Formation of Precise Plasmonic Nanojunctions within Aggregates of Gold Nanoparticles and Cucurbit[n]uril
Published on: October 3, 2020
Related Concept Videos
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Secondary Active Transport
Secondary Active Transport
Oral Hypoglycemic Agents: Biguanides and Glitazones
Dipeptidyl Peptidase 4 Inhibitors